Showing results (2071-2080 of 6,713) with videos related to

Sort By:
Pageof 672
Oncotargets and Therapy|May 3, 2019
Sunitinib-and-Chinese herbal medicine-based systematic treatment clinically cured a patient with multiple metastatic primary clear cell carcinoma of the liver: a case reportLingling Sun, Hanrui Chen, Zhiwei Xiao, et al.
Oncotargets and Therapy|September 27, 2018
Low-frequency ultrasound enhances chemotherapy sensitivity and induces autophagy in PTX-resistant PC-3 cells via the endoplasmic reticulum stress-mediated PI3K/Akt/mTOR signaling pathwayYuqi Wu, Xiaobing Liu, Zizhen Qin, et al.
Oncotargets and Therapy|September 27, 2018
Helicobacter pylori promotes gastric epithelial cell survival through the PLK1/PI3K/Akt pathwayWenting Xu, Ying Huang, Zhen Yang, et al.
Oncotargets and Therapy|September 27, 2018
Targeted cancer therapy using engineered exosome as a natural drug delivery vehicleHosna Gomari, Mehdi Forouzandeh Moghadam, Masoud Soleimani
Oncotargets and Therapy|September 27, 2018
Combined detection of IL-6 and IL-8 is beneficial to the diagnosis of early stage esophageal squamous cell cancer: a preliminary study based on the screening of serum markers using protein chipsQiang Tong, Xiao-Long Wang, Sheng-Bao Li, et al.
Oncotargets and Therapy|September 27, 2018
Subgroup analysis reveals molecular heterogeneity and provides potential precise treatment for pancreatic cancersHeying Zhang, Juan Zeng, Yongqiang Tan, et al.
Oncotargets and Therapy|April 10, 2019
Effect of 21-gene recurrence score in decision-making for surgery in early stage breast cancerSan-Gang Wu, Wen-Wen Zhang, Jun Wang, et al.
Oncotargets and Therapy|April 10, 2019
miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9Hao Zhang, Zhenya Zhang, Lili Gao, et al.
Oncotargets and Therapy|May 2, 2019
The diagnostic value of circulating tumor cells and ctDNA for gene mutations in lung cancerMengyuan Lyu, Jian Zhou, Kang Ning, et al.
Oncotargets and Therapy|May 2, 2019
Clinical efficacy and survival analysis of apatinib combined with docetaxel in advanced esophageal cancerJing Li, Yongxu Jia, Yaping Gao, et al.
Pageof 672